82 companies

China Resources Sanjiu Medical & Pharmaceutical

Market Cap: CN¥52.9b

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.

000999

CN¥31.55

7D

-1.0%

1Y

-3.4%

Tonghua Golden-Horse Pharmaceutical Industry CoLtd

Market Cap: CN¥21.7b

Engages in the research, development, manufacture, and sale of pharmaceutical products in China.

000766

CN¥23.29

7D

4.9%

1Y

64.9%

Sichuan Biokin PharmaceuticalLtd

Market Cap: CN¥118.8b

Engages in the research and development, production, and marketing of small molecule chemical, molecular biological, and antibody-drug conjugate drugs in China and internationally.

688506

CN¥312.56

7D

2.1%

1Y

80.5%

Yili Chuanning BiotechnologyLtd

Market Cap: CN¥27.4b

Engages in the research, development, and industrialization of bio-fermentation technology and synthetic biology products in China and internationally.

301301

CN¥12.40

7D

-0.5%

1Y

9.4%

Telix Pharmaceuticals

Market Cap: AU$5.6b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

TLX

AU$17.13

7D

-7.8%

1Y

-7.1%

Pfizer

Market Cap: ₹233.4b

Engages in manufacturing, marketing, trading, and distribution of pharmaceutical products in India and internationally.

PFIZER

₹5,107.00

7D

1.1%

1Y

-11.5%

Haw Par

Market Cap: S$3.1b

Manufactures, markets, and trades in healthcare products in Singapore, The Association of Southeast Asian Nations countries, other Asian countries, and internationally.

New

H02

S$14.24

7D

1.1%

1Y

39.2%

Pacific Shuanglin Bio-pharmacy

Market Cap: CN¥17.6b

Pacific Shuanglin Bio-pharmacy Co., Ltd. engages in research, development, production, and sales of blood products in China.

000403

CN¥18.23

7D

-1.8%

1Y

-5.5%

Grand Pharmaceutical Group

Market Cap: HK$28.3b

An investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical preparations and medical devices, biotechnology and healthcare products, and pharmaceutical raw materials.

512

HK$8.29

7D

0.1%

1Y

83.8%

WuXi XDC Cayman

Market Cap: HK$68.9b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

2268

HK$61.95

7D

5.7%

1Y

250.8%

Page 3 of 3